Rocket


News + Filings
Transactions





McLoughlin Margaret

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
08/08/2023Quince Therapeutics, Inc.CRTXPurchaseCommon Stock8k$1.23$9.8k 08/08/2023
05/24/2023Quince Therapeutics, Inc.CRTXGrantStock Option (right to buy)27k$1.58$42.7k 05/24/2023
06/08/2022Quince Therapeutics, Inc.CRTXGrantStock Option (right to buy)27k$3.23$87.2k 06/08/2022
10/08/2021Quince Therapeutics, Inc.CRTXExerciseStock Option (right to buy)1000$17.00$17k 10/08/2021
10/08/2021Quince Therapeutics, Inc.CRTXSaleCommon Stock1000$88.93$88.9k 10/08/2021
06/28/2021Quince Therapeutics, Inc.CRTXSaleCommon Stock100$55.73$5.6k 06/28/2021
06/28/2021Quince Therapeutics, Inc.CRTXSaleCommon Stock250$55.03$13.8k 06/28/2021
06/28/2021Quince Therapeutics, Inc.CRTXSaleCommon Stock200$55.01$11k 06/28/2021
06/16/2021Quince Therapeutics, Inc.CRTXGrantStock Option (right to buy)11k$50.56$557.6k 06/16/2021
06/08/2020Quince Therapeutics, Inc.CRTXGrantStock Option (Right to Buy)11k$41.73$460.2k 06/08/2020
05/13/2019Quince Therapeutics, Inc.CRTXPurchaseCommon Stock550$17.00$9.4k 05/13/2019
05/08/2019Quince Therapeutics, Inc.CRTXGrantStock Option (Right to buy)91.9k$17.00$1.6M 05/08/2019

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy